Buy Flubromazepam Pure
€ 90,00 – € 360,00Price range: € 90,00 through € 360,00
Flubromazepam Pure is a catalog designation associated with flubromazepam, a synthetic brominated and fluorinated 1,4-benzodiazepine derivative.
The compound is distinguished by its reported 7-bromo and 2-fluorophenyl substituents and is relevant to analytical investigations involving benzodiazepine chemical identity, structural characterization, forensic toxicology, and positional-isomer differentiation.
The supplied information describes a crystalline powder presentation and reports the molecular formula C15H10BrFN2O.
However, the term “Pure” does not establish independently verified purity, and the claimed ingredient purity, analytical testing, reference-material certification, and storage conditions require actual product-specific documentation.
No certified reference-material status, accredited testing, or validated quantitative calibration performance has been established for the Raw Lab Chems listing.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Flubromazepam Pure – Brominated Benzodiazepine Research Material
Product Overview
Flubromazepam Pure is a catalog designation associated with flubromazepam, a synthetic compound belonging to the 1,4-benzodiazepine chemical family.
Flubromazepam is characterized by a brominated benzodiazepine framework and a fluorinated phenyl substituent.
These structural characteristics distinguish the compound from other benzodiazepine derivatives and provide a basis for analytical investigations involving chemical identification, chromatographic differentiation, and spectroscopic characterization.
The supplied source describes flubromazepam as a compound first synthesized in the 1960s and subsequently encountered in research chemical and forensic analytical contexts.
These historical statements are reproduced as background information rather than independently verified product specifications.
Raw Lab Chems presents this material exclusively within a Research Use Only framework.
The supplied source describes a crystalline powder presentation.
However, no actual Raw Lab Chems batch-specific analytical report, product inspection record, or independent certification accompanied the information.
The product name does not independently establish ingredient purity, chemical identity, or reference-material certification.
No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.
Chemical Identity & Classification
Flubromazepam is described in the supplied source as a brominated and fluorinated 1,4-benzodiazepine derivative.
Its reported structure includes a bromine substituent on the benzodiazepine framework and a fluorine substituent on the attached phenyl group.
The supplied source provides the following chemical-reference information:
- Common name: Flubromazepam
- Reported systematic name: 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- Chemical classification: Halogenated 1,4-benzodiazepine derivative
- Reported CAS Registry Number: 2647-50-9
- Reported molecular formula: C15H10BrFN2O
- Reported molecular weight: 333.16 g/mol
- Reported InChIKey: ZRKDDZBVSZLOFS-UHFFFAOYSA-N
These identifiers are reproduced from the supplied source and do not independently verify the identity of the actual product.
The reported molecular formula and molecular weight are approximately consistent with one another.
However, mathematical consistency does not establish that the actual material has been independently characterized.
The source also provides a SMILES representation, but no authenticated structural record or batch-specific spectroscopic data accompanied it.
The chemical form, impurity profile, and composition of the actual Raw Lab Chems material remain unverified.
Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.
Chemical & Physical Characteristics
The supplied source describes flubromazepam as a white to off-white crystalline powder.
This is a source-provided physical description rather than a verified observation of the actual Raw Lab Chems product.
The source also reports a melting point of approximately 188°C.
No melting-point determination report, measurement conditions, or batch-specific physical characterization accompanied that statement.
The compound’s proposed molecular structure contains a benzodiazepine ring system with brominated and fluorinated substituents.
These structural features provide a basis for analytical differentiation from related halogenated benzodiazepines.
However, structural similarity does not establish identical physical properties, stability, impurity profiles, or analytical behavior.
The supplied source mentions methanol, acetonitrile, dimethylformamide, and dimethyl sulfoxide in connection with solubility.
No quantitative solubility data, experimental conditions, or independently verified solubility profile was supplied.
The source does not provide a verified particle-size distribution, density, hygroscopicity measurement, or polymorphic characterization.
No validated degradation profile or experimentally established shelf-life specification accompanied the supplied physical descriptions.
Accordingly, appearance, melting behavior, solubility, and stability should not be treated as verified product specifications without supporting documentation.
Purity & Analytical Verification
The supplied source claims ingredient purity of at least 98% and refers to analytical quality-control procedures.
However, no actual Raw Lab Chems batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.
Accordingly, the stated purity threshold is not independently confirmed for the material described here.
The source identifies LC-MS/MS, GC-MS, infrared spectroscopy, and NMR as analytical techniques relevant to flubromazepam investigation.
Such techniques may provide information concerning chemical identity, structural characteristics, impurity profiles, and differentiation from related compounds.
However, naming an analytical technique does not establish that it was performed on the actual product.
The source also discusses positional isomers and the importance of distinguishing structurally related benzodiazepines. Flubromazepam Pure
These references provide scientific context but do not establish that the supplied product has undergone independently verified isomer-specific characterization.
A particularly important distinction exists between ordinary research material and a certified reference material.
The source uses certified-reference-material terminology and claims that accredited reference-material options are available.
However, no certificate, assigned value, uncertainty statement, metrological traceability record, or accreditation evidence was supplied for the actual Raw Lab Chems listing.
The product should therefore not be described as a certified reference material without suitable supporting documentation.
Quality Control & Batch Integrity
The supplied promotional source claims rigorous quality-control procedures, high ingredient purity, controlled storage, and double-sealed packaging.
It also references ISO/IEC 17025 and ISO 17034 in connection with certified reference-material options.
These claims originated in promotional material associated with another supplier.
They cannot be attributed to Raw Lab Chems without independent documentation.
No actual Raw Lab Chems batch-specific analytical certificate, manufacturing audit, laboratory accreditation document, or quality-system record accompanied the information.
For reproducible laboratory investigation, useful records may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.
The source does not establish independently verified batch-to-batch consistency, impurity specifications, quantitative purity, or metrological traceability.
A general statement that analytical documentation is available should not be interpreted as confirmation that a specific document exists for the actual batch.
Where certified reference-material status is claimed, the supporting certificate should identify the exact material, assigned characteristics, measurement uncertainty, and relevant traceability information.
No such certification is established here.
Safety, Handling & Laboratory Precautions
Flubromazepam is a benzodiazepine-related compound requiring appropriate institutional risk assessment and controlled laboratory handling.
The supplied source associates the compound with prolonged pharmacological activity and central nervous system depressant hazards.
These statements are relevant to hazard awareness but do not establish a verified toxicological profile for the actual product.
Research personnel should consult available chemical-safety documentation and institutional procedures before receiving or examining the material. Flubromazepam Pure
Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.
The compound’s structural relationship to other benzodiazepines does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual purity and chemical form have not been independently confirmed, laboratory records should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes double-sealed packaging, temperature-controlled logistics, and tracked transportation.
No Raw Lab Chems packaging-validation study, verified container specification, shipment-condition record, or carrier documentation accompanied these claims.
The source recommends dry, dark storage under controlled temperature conditions and suggests approximately −20°C for longer-term preservation.
It also refers to stability of analytical reference solutions under appropriate conditions.
However, no validated product-specific stability study, solution-stability report, or experimentally established shelf-life specification was supplied. Flubromazepam Pure
The suggested storage temperature therefore remains an unverified source recommendation.
Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.
Where chemical form, purity, or packaging characteristics remain uncertain, the inventory record should preserve those uncertainties rather than assign unverified details.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
No guarantee concerning container integrity, transportation conditions, or long-term stability is implied.
Intended Research Use & Market Positioning
The supplied scientific context places flubromazepam within analytical research involving halogenated benzodiazepines, chemical identification, structural comparison, and forensic toxicology. Flubromazepam Pure
Its brominated and fluorinated molecular framework provides a basis for differentiating it from other benzodiazepine-related compounds in appropriately validated analytical investigations.
The source references chromatographic identification, spectroscopic characterization, and examination of structurally related positional isomers.
These references describe laboratory research contexts and do not establish any human-use application.
The supplied Raw Lab Chems catalog includes Flubromazepam Pure, corresponding to the listing discussed here.
The catalog also includes Flubromazepam Powder, a separately named presentation associated with the same compound. Flubromazepam Pure
The supplied information does not establish whether these two listings represent distinct grades, packaging formats, batches, or duplicate catalog entries.
For broader benzodiazepine catalog context, Raw Lab Chems also lists Norflurazepam Blister.
Norflurazepam is a different named compound and should not be treated as chemically identical or analytically interchangeable with flubromazepam.
These references provide catalog context rather than evidence of certified reference-material status or equivalent product specifications.
Ordering, Availability & Fulfillment
The supplied promotional source includes claims concerning pack sizes, current stock, European shipping coverage, same-day dispatch, carrier services, payment methods, and delivery time frames.
However, these statements reference another supplier and are not verified Raw Lab Chems fulfillment specifications. Flubromazepam Pure
No current Raw Lab Chems inventory record, shipping schedule, destination-specific authorization, or carrier documentation was supplied.
Consequently, no particular availability, delivery period, shipping cost, customs-clearance arrangement, or transportation-compliance guarantee is asserted.
Flubromazepam may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved. Flubromazepam Pure
Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.
Research-only labeling does not establish an exemption from controlled-substance regulations.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Flubromazepam is a benzodiazepine-related compound whose acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analogue, pharmaceutical, or other chemical regulations.
The supplied source describes flubromazepam as a non-approved designer benzodiazepine, but the exact current legal classification was not independently verified for this listing.
Researchers and institutions remain responsible for determining the applicable legal requirements and obtaining any necessary authorizations.
No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.
| Quantity |
1 grams ,5 grams |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.